Ocuphire Pharma Q2 EPS $(0.52) Down From $(0.43) YoY

Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.

byBill Haddad

August 12, 2021

1 minute read

Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.

Barclays Maintains Equal-Weight on Rivian Automotive, Lowers Price Target to $47

By Benzinga Newsdesk

Today, 4:07 PM

Barclays analyst Brian Johnson maintains Rivian Automotive (NASDAQ:RIVN) with a Equal-Weight and lowers the price target from $115 to $47.

RIVN

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher

By Lisa Levin

Today, 4:07 PM

Toward the end of trading Tuesday, the Dow traded down 0.86% to 34,488.53 while the NASDAQ fell 0.08% to 14,626.98. The S&P also fell, dropping 0.48% to 4,331.47.

ADXS

Cryptocurrencies Like Bitcoin And Ethereum Can’t Shake The Risk Asset Tag: What’s Holding Them Back

By Murtuza Merchant

Today, 4:07 PM

When cryptocurrencies first started gaining the attention of mainstream investors in early 2017, a number of crypto pundits were quick to claim that they could act as an effective hedge against inflation.

BTC

FTI Consulting Q4 Adj. EPS $1.13 Beats $1.02 Estimate, Sales $676.20M Beat $671.79M Estimate

By Benzinga Newsdesk

Today, 4:07 PM

FTI Consulting (NYSE:FCN) reported quarterly earnings of $1.13 per share which beat the analyst consensus estimate of $1.02 by 10.78 percent. This is a 29.81 percent decrease over earnings of $1.61 per share from the

FCN

Ocuphire Pharma Q2 EPS $(0.52) Down From $(0.43) YoY

Related Posts

Barclays Maintains Equal-Weight on Rivian Automotive, Lowers Price Target to $47

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher

Cryptocurrencies Like Bitcoin And Ethereum Can’t Shake The Risk Asset Tag: What’s Holding Them Back

FTI Consulting Q4 Adj. EPS $1.13 Beats $1.02 Estimate, Sales $676.20M Beat $671.79M Estimate